Table 3 Comparative cost analysis for clinical management of COVID-19 cases with and without underlying diseases.
From: Estimated cost of treating hospitalized COVID-19 patients in Saudi Arabia
Classification | Without underlying diseases | With underlying diseases | P-value | ||
|---|---|---|---|---|---|
Cost Mean (SD) USD | Median (IQR) | Cost Mean (SD) USD | Median (IQR) | ||
Accommodation (Bed cost) | 315 (70) | 134 (229) | 892 (197) | 200 (354) | 0.028 |
Laboratory works | 655 (169) | 123 (707) | 2517 (642) | 312 (1354) | 0.031 |
Diagnostic radiology exams | 486 (321) | 7.2 (107) | 388 (55) | 49 (287) | 0.159 |
Treatment Medications | 1040 (118) | 429 (1143) | 17,388 (1679) | 208 (867) | The |
Nonpharmaceutical (devices, fluid, Intubation, monitoring, and equipment in ICU) | 2246 (533) | 1218 (2844) | 6950 (935) | 2611 (5367) | 0.002 |
